Navigation Links
Finding May Lead to New Drugs for Urinary Infections
Date:2/20/2009

Researchers seek way to destroy bad, not good, E. coli,,

FRIDAY, Feb. 20 (HealthDay News) -- Potential targets for new drugs to fight the bacteria that cause many urinary tract infections have been identified by U.S. researchers.

Two molecules called yersiniabactin and salmochelin enable E. coli to steal iron from their hosts, which makes it easier for the bacteria to survive and reproduce. Identifying the two molecules -- called siderophores -- could help lead to the development of antibiotics that target pathogenic E. coli strains without harming beneficial bacteria in the gut.

The findings appear in the Feb. 20 issue of PLoS Pathogens.

"When we treat an infection with antibiotics, it's like dropping a bomb -- nearly everything gets wiped out, regardless of whether it's helpful or harmful. We'd like to find ways to target the bad bacteria and leave the good bacteria alone, and these siderophores are a great lead in that direction," study author Jeff Henderson, of the Center for Women's Infectious Disease Research at Washington University School of Medicine in St. Louis, said in a Public Library of Science news release.

The E. coli bacteria that cause urinary tract infections might come from the human gut, where several strains of the bacteria reside. But it's believed that other strains help aid digestion and block other infectious organisms.

For their study, Henderson and his colleagues used a method called metabolomics to study the differences between disease-causing and friendly E. coli strains. Metabolomics involves analyzing all the chemicals produced by a cell, including growth signals, toxins and waste products.

"This allows us to look at the end products of many genes working together," senior study author Scott Hultgren explained in the news release. "We assess what all the various assembly lines are producing and which products disease-causing bacteria prefer to make, such as certain siderophores."

Drugs that block or disrupt the activity of the proteins that make siderophores could be one way to fight disease-causing bacteria. Another approach is what the researchers call a "Trojan horse" strategy.

"To steal iron, siderophores have to be sent out from the cell, bind to the iron and then be taken back into the cell," Henderson said. "If we can design an antibiotic that looks like a siderophore, we might be able to trick only disease-causing bacteria into taking up the drug while leaving other bacteria alone."

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about urinary tract infections.



-- Robert Preidt



SOURCE: Public Library of Science, news release, Feb. 19, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. JAMA article contends earlier study overstated validity of findings on bisphenol A
2. Findings raise new questions about evolution of hormones in mammals
3. Center for the Study of Traumatic Encephalopathy announces new findings
4. New findings on old kidneys could enhance transplants, Stanford study shows
5. Wynonna Judd Reveals Her alli(R), Her Story for Finding a Healthier Lifestyle
6. New findings shed light on why smokers struggle to quit
7. Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
8. Finding Grace on a Less Traveled Road: A Cancer Doctor Reflects on Living and Dying
9. Breast cancer in men: Mammography and sonography findings
10. Initial Survey Findings on Diabetes Awareness Released by PatientAssistance.com
11. Finding Points to Possible Blood Test for Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Finding May Lead to New Drugs for Urinary Infections
(Date:1/24/2017)... ... January 24, 2017 , ... PeroxyChem Food and ... Control Equipment (PACE), at the International Production and Processing Expo (IPPE) in Atlanta, ... the new technology that is used in poultry processing facilities to provide constant, ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... advance to the semi-final round of the 2017 Cupid's Cup Entrepreneurship Competition. Chaired ... its 12th year in 2017. The entrepreneurs will showcase their businesses on February ...
(Date:1/24/2017)... ... ... Bellus Medical, a leader in medical aesthetics, today announced that Marek Dobke, ... Dobke will provide physician oversight for in-house clinical studies and hands-on device training, among ... Associate Professor of Surgery at UC San Diego Health and is a board certified ...
(Date:1/24/2017)... MA (PRWEB) , ... January 24, 2017 , ... ... They Really Need to Thrive , Well-meaning studies such as the Fordham Institute’s ... schools can better serve top students, such as including gifted or high-achieving students ...
(Date:1/24/2017)... ... 2017 , ... Today, Taza Agua, Costa Rica's leading supplier ... to optimize the drinking experience for K-Cup coffee, tea and hot chocolate connoisseurs ... first untouched bottled water purposed exclusively for creating a superior brew. The company ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... PUNE, India , January 24, 2017 ... Allied Market Research, titled, "Cold Chain Logistics Market by ... & Frozen Dessert, Meat, Fish & Sea Food, Drugs ... Industry Forecasts, 2014-2022," projects that the global cold chain ... 2022, growing at a CAGR of 16% (2016 to ...
(Date:1/24/2017)... Analysis of the Liquid Biopsy Market by ... - our new study reveals trends, R&D progress, and predicted revenues ... involved in this sector you must read this brand new report. ... 2027, assessing data, trends, opportunities and business prospects there. ... Discover How to Stay Ahead ...
(Date:1/24/2017)... Md. , and GAITHERSBURG, Md. , ... XON ), a leader in the engineering and industrialization ... of the planet, today announced that it has entered into ... GNVC ), a clinical-stage company and pioneer in ... Intrexon intends to integrate and expand upon GenVec,s expertise in ...
Breaking Medicine Technology: